Menu UF Health Home Menu
 

Diabetes Complications

Name PI
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Event (DEVOTE) Margaret Lo, M.D.
Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes Demetra Christou, Ph.D.

Non-Alcoholic Fatty Liver Disease in Gestational Diabetes

Sattari, Maryam, M.D.
SONAR: Study Of Diabetic Nephropathy with Atrasentan Karen Hall, M.D.
A Pharmacodynamic Comparison of Prasugrel Vs. Ticagrelor in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease Dominick J. Angiolillo, M.D., Ph.D.
A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment with BELVIQ (lorcaserin HCI) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects with Cardiovascular Disease or Multiple Cardiovascular Risk Factors CAMELLIA Dominick J. Angiolillo, M.D., Ph.D.
A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg administered orally once daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk Kent Wehmeier, M.D.
A Randomized, Double-Blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus Jason A. Piraino, D.P.M.
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS)
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects with Type 2 Diabetes at High Risk of Cardiovascular Events Joe Chehade, M.D.
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control, (Protocol-M) Kakarla V. Chalam, M.D., Ph.D.
Roles of GLUT 1 and Glucose in the Progression of Nondiabetic Glomerulosclerosis Charles Heilig, Ph.D.
Efficacy and Safety of Switching from Sitagliptin to Liraglutide in Subjects with Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin Protocol: NN2211-4059 Mae Sheikh-Ali, M.D., Kent Wehmeier, M.D.
The Association Between Serum Vitamin D Levels, Obesity, and Obstructive Sleep Apnea Mae Sheikh-Ali, M.D.
Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes Jeffery Harrison, Ph.D.
Bone marrow neuropathy drives diabetic retinopathy Jeffery Harrison, Ph.D.
Oral delivery of bioencapsulated ACE2 and Ang1-7 for therapy of diabetic retinopathy Qiuhong Li, Ph.D.
No-longer recruiting | In follow-up
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesion (ABSORB III) 
Early Indices of Auditory Pathology in Young Adults with Diabetes
IRIS – Insulin Resistance Intervention After Stroke Trial
The Influence of Periodontal Treatment on Gingival Inflammatory Response of the Type II Diabetic Patient